Robert Kruit – Chief Executive, Zuellig Pharma Malaysia & Brunei

Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond distribution and diversify its offering in the healthcare sector, and how Zuellig’s investments into digital health, commercial solutions, and animal health further the goal of making healthcare more accessible.  
The pharmaceutical segment [in Malaysia] will continue to grow. Given that it is a large market and growing at a relatively fast rate, it remains an area of potential.
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report